UPXI: Upexi, Inc. Stock

by  •  • Comments Off on UPXI: Upexi, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 3.81
Enterprise Value ($M) 10.08
Book Value ($M) 5.03
Book Value / Share 4.83
Price / Book 0.76
NCAV ($M) -6.78
NCAV / Share -6.51
Price / NCAV -0.56

Profitability (mra)
Return on Invested Capital (ROIC) -1.52
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.94

Liquidity (mrq)
Quick Ratio 0.53
Current Ratio 0.69

Balance Sheet (mrq) ($M)
Current Assets 6.79
Assets 18.60
Liabilities 13.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 26.00
Operating Income -21.27
Net Income -23.66

Cash Flow Statement (mra) ($M)
Cash From Operations -0.10
Cash from Investing -3.38
Cash from Financing -0.35

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-12-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-07-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 1,097 9,259 11.85
2025-02-03 2,827 14,269 19.81
2025-01-31 11,370 45,465 25.01
2025-01-30 6,895 23,918 28.83

(click for more detail)

Similar Companies
TTNP – Titan Pharmaceuticals, Inc. UNCY – Unicycive Therapeutics, Inc.
UPC – Universe Pharmaceuticals INC VERU – Veru Inc.
VINC – Vincerx Pharma, Inc.


Financial data and stock pages provided by
Fintel.io